RAIMONDI, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 1.804
EU - Europa 437
AS - Asia 271
SA - Sud America 12
AF - Africa 11
OC - Oceania 1
Totale 2.536
Nazione #
US - Stati Uniti d'America 1.790
IT - Italia 156
SG - Singapore 102
IN - India 96
DE - Germania 84
SE - Svezia 70
CN - Cina 57
FI - Finlandia 50
UA - Ucraina 19
GB - Regno Unito 16
BG - Bulgaria 14
CA - Canada 12
TG - Togo 10
AR - Argentina 9
IE - Irlanda 9
RO - Romania 6
CH - Svizzera 5
BR - Brasile 3
FR - Francia 3
JP - Giappone 3
HK - Hong Kong 2
IL - Israele 2
MX - Messico 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
EE - Estonia 1
IR - Iran 1
KR - Corea 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MY - Malesia 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PL - Polonia 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 2.536
Città #
Fairfield 297
Chandler 190
Ashburn 155
Seattle 132
Houston 116
Woodbridge 112
Cambridge 93
Wilmington 83
Singapore 69
Rome 63
Princeton 52
Ann Arbor 48
Plano 43
Dearborn 41
Grafing 41
Lawrence 35
San Paolo di Civitate 34
Beijing 30
Boston 27
Des Moines 24
Millbury 19
San Diego 19
Helsinki 16
Fremont 15
New York 14
Sofia 14
Andover 11
Lomé 10
Santa Clara 10
Toronto 10
Dublin 9
Bremen 8
Federal 8
Munich 7
Kunming 6
Nanjing 6
Phoenix 6
Hefei 5
Bern 4
Bühl 4
Falls Church 4
Liverpool 4
Norwalk 4
Guangzhou 3
Priverno 3
Redmond 3
Arezzo 2
Ariccia 2
Boardman 2
Florence 2
Foggia 2
Gunzenhausen 2
Hong Kong 2
Islington 2
Jacksonville 2
Kilburn 2
London 2
Los Angeles 2
Mannheim 2
Naples 2
Southend 2
São Paulo 2
Almaty 1
Auckland 1
Bangalore 1
Bari 1
Basking Ridge 1
Bratislava 1
Buffalo 1
Canuelas 1
Chicago 1
Colombo 1
Coventry 1
Dalmine 1
Denver 1
Dubai 1
Edinburgh 1
Falkenstein 1
Frankfurt 1
Frankfurt am Main 1
Gangdong-gu 1
Genova 1
Gothenburg 1
Groningen 1
Haifa 1
Hangzhou 1
Hanoi 1
Jinhua 1
Laurel 1
Leawood 1
Manila 1
Milan 1
Muizenberg 1
North York 1
Nutley 1
Ottawa 1
Padova 1
Parma 1
Redwood City 1
Rignano Flaminio 1
Totale 1.977
Nome #
Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab 107
Transient disappearance of RAS mutant clones in plasma: A counterintuitive clinical use of EGFR inhibitors in RAS mutant metastatic colorectal cancer 102
Circulating tumor cells identify patients with super-high-risk non-muscle-invasive bladder cancer: updated outcome analysis of a prospective single-center trial 100
Liquid Biopsy in Rare Cancers: Lessons from Hemangiopericytoma 92
Circulating tumor cells in right-and left-sided colorectal cancer 88
EpCAM expressing circulating tumor cells in colorectal cancer 87
Circulating tumor cells count and characterization in a male breast cancer patient 84
Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization. 81
The rationale for liquid biopsy in colorectal cancer: a focus on circulating tumor cells 80
The role of capecitabine in the management of breast cancer in elderly patients 78
PD-L1 and epithelial-mesenchymal transition in circulating tumor cells from non-small cell lung cancer patients: a molecular shield to evade immune system? 78
The long-term prognostic value of survivin expressing circulating tumor cells in patients with high-risk non-muscle invasive bladder cancer (NMIBC) 76
EGFR inhibitor as second-line therapy in a patient with mutant RAS metastatic colorectal cancer: circulating tumor DNA to personalize treatment 76
Circulating tumor cells detection has independent prognostic impact in high-risk non-muscle invasive bladder cancer 74
Cancer stem cells and epithelial-mesenchymal transition: revisiting minimal residual disease. 74
Molecular Characterization of Circulating Tumor Cells to Study Cancer Immunoevasion 71
Circulating tumor cells, colon cancer and bevacizumab: the meaning of zero. 71
Comment on: isolation and characterization of tumorigenic extrahepatic cholangiocarcinoma cells with stem cell-like properties 68
Circulating tumor cells in high-risk nonmetastatic colorectal cancer 67
Circulating tumor cells: Exploring intratumor heterogeneity of colorectal cancer 64
Circulating Tumor Cells in Cancer Therapy: Are we off Target? 63
Molecular markers in circulating tumour cells from metastatic colorectal cancer patients 61
Weekly combination of non-pegylated liposomal doxorubicin and taxane in first-line breast cancer: wALT trial (phase I-II) 61
Neoadjuvant targeted therapy in renal cell carcinoma 58
Impact of chronic exposure to bevacizumab on EpCAM-based detection of circulating tumor cells 54
Circulating tumor cells in metastatic colorectal cancer: do we need an alternative cutoff? 53
Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysis. 51
The End of Chemotherapy in Renal Cell Carcinoma: For Much But Not for All 49
Circulating tumor cells lacking cytokeratin in breast cancer: the importance of being mesenchymal 49
Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients 48
Controversies in circulating tumor cell count during therapy 48
How circulating tumor cells escape from multidrug resistance: translating molecular mechanisms in metastatic breast cancer treatment. 46
Circulating tumor cells: highlight on practical implications. 41
Circulating tumor cells in early bladder cancer: insight into micrometastatic disease 39
Circulating tumor cells and "suspicious objects" evaluated through CellSearch® in metastatic renal cell carcinoma. 37
Clinical utility of circulating tumor cell counting through CellSearch(®): the dilemma of a concept suspended in Limbo. 37
Anaemia and erythropoietic growth factors supportive treatments in colorectal cancer 36
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data. 36
Start-therapy in cancer pain management: news from the past 35
Circulating tumor cells isolation: The “post-EpCAM era” 34
Anemia As A Predictive Factor In Colorectal Cancer (CRC) Patients (PTS) 31
Circulating tumor cells in young and elderly patients with colorectal cancer: "lupus et agnus". 19
null 19
null 17
BIS ETORICOXIB AND ANASTROZOL: NEW FRONTIERS IN. BREAST CANCER TARGET THERAPY? 15
Hpv and cancer. Is this all Eve's fault? 14
Totale 2.669
Categoria #
all - tutte 7.470
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.470


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020494 0 0 0 20 60 95 88 64 65 58 32 12
2020/2021237 22 18 18 13 7 14 2 5 23 100 14 1
2021/2022463 3 21 46 11 60 8 16 52 26 40 88 92
2022/2023557 96 118 31 63 68 74 12 26 43 3 21 2
2023/2024247 13 34 7 26 23 40 3 26 1 42 20 12
2024/2025100 12 30 46 12 0 0 0 0 0 0 0 0
Totale 2.669